Original news and analysis on international IP policy
By Paul Garwood Kenya’s Parliament has rejected a proposal to revoke the government’s powers to issue compulsory licenses to manufacture products such as generic medicines without patent holder approval, a move welcomed Friday by supporters of universal access to pharmaceuticals.…
By Paul Garwood Kenyan lawmakers are set to debate proposed amendments to a bill that, if passed, would prevent the government from issuing compulsory licenses to produce urgently needed medicines without seeking approval from the patent holder. The amendments, which…
By David Cronin for Intellectual Property Watch A dispute has erupted between two of the European Union’s most powerful institutions over Thailand’s decision to circumvent pharmaceutical patents in order to boost its supply of cheap medicines. Peter Mandelson, who holds…
By Tove Iren S. Gerhardsen The World Health Organization is inviting participation in a six-week online public hearing from anyone interested in commenting on an ongoing process on how to ensure treatments for neglected diseases mainly found in developing countries.…
Par Tove Iren S. Gerhardsen Le nouveau document de négociation de l’Organisation mondiale de la santé (OMS) élaboré en vue du dernier cycle de ce qui est devenu un intense processus d’analyse de l’innovation médicale et de la propriété intellectuelle…
Por Tove Iren S. Gerhardsen El nuevo proyecto de documento de negociación de la Organización Mundial de la Salud (OMS) destinado a la última ronda de lo que se ha convertido en un proceso intenso de análisis sobre innovación de…
By Tove Iren S. Gerhardsen The World Health Organization’s (WHO) new draft negotiating document for the final round of what has become an intense process of analysing medicines innovation and intellectual property narrows the focus to about a dozen diseases…
By Tatum Anderson for Intellectual Property Watch As Indian lawyers for Swiss pharmaceutical firm Novartis comb through a High Court judgment published today, the question of whether the Indian patent law is compliant with a World Trade Organization treaty remains…
By Tove Iren S. Gerhardsen The United States has begun incorporating a revised intellectual property and health policy into its bilateral trade deals. But although the overall softer approach towards its partners may improve access to medicines, the debate on…
By Tove Iren S. Gerhardsen Years after it was permitted under international trade law, the first country has notified the World Trade Organization that it will use a flexibility allowing it to address public health needs by importing a patented…